女性原发性腹膜癌27例临床及病理分析  

Clinical and Pathological Analysis on 27Cases of Female Primary Peritoneal Carcinoma

作　　者：刘文欣[1] 王珂[1] 刘素香[2] 张燮良[1] 

机构地区：[1]天津医科大学附属肿瘤医院盆腔科,天津市300060 [2]天津医科大学附属肿瘤医院病理科

出　　处：《中国肿瘤临床》2002年第4期285-288,共4页Chinese Journal of Clinical Oncology

摘　　要：目的:探讨原发性腹膜癌(PPC)的临床特点、诊断标准、治疗方法和预后。方法:对1993年1月～2000年12月在本院治疗的27例PPC患者的临床资料进行回顾性分析,其结果均经病理检查证实。结果:27例中,浆液性乳头状腺癌21例,粘液性乳头状腺癌4例,子宫内膜样癌1例,低分化癌1例。全部病例均施行肿瘤细胞减灭术,术后予以铂类为主方案的化疗。27例中3例失访,余24例中位生存期为28个月。结论:PPC原发于腹膜,是一种起病隐袭、发病率较低的疾病。应重视其术前诊断及鉴别诊断,减少误诊率。对PPC采取肿瘤细胞减灭术及铂类为主方案的化疗可显著改善预后,延长生存期。Objective:To investigate the clinical features,diagnostic criterion,treatment and prognosis of female primary peritoneal carcinoma (PPC).Methods:Twenty-seven cases of histologically confirmed PPC cases treated in our hospital from1993to2000were retrospectively analysed.Results:In this series,21cases were proved as serous papillary adenocarcinoma and the remaining cases were mucous(4cases),endometrioid(1case)and low differentiated carcino-ma (1case).All patients were given cytoreductive surgery and platin-based chemotherapy.Twenty-four patients were followed up and the median survival time reached28months.Con-clusion:PPC is a rare tumor.The initial definite diagnosis is difficult and the attention should be paid to differential diagnosis.The new diagnostic criterion of PPC is mentioned in this arti-cle.Long time survival can be achieved in some patients by cytoreductive surgery and platin-based chemotherapy.

关 键 词：原发性腹膜癌 预后 女性 病理 PPC 

分 类 号：R735.5[医药卫生—肿瘤]